darunavir/cobicistat/emtricitabine/tenofovir alafenamide
General
General
General
Genetic Implications: 
Pronunciation:
da-roo-na-veer/koe-bik-i-stat/em-tri-si-ti-been/te-noe-fo-veer al-a-fen-a-mide
To hear audio pronunciation of this topic, purchase a subscription or log in.
Trade Name(s)
Ther. Class.
antiretrovirals
pharmacoenhancers
Pharm. Class.
protease inhibitors
enzyme inhibitors
nucleoside reverse transcriptase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
TY - ELEC
T1 - darunavir/cobicistat/emtricitabine/tenofovir alafenamide
ID - 110745
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/110745/all/darunavir_cobicistat_emtricitabine_tenofovir_alafenamide
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -
Try the app for free!
1. Download the Davis's Drug Guide app by Unbound Medicine
2. Select Try/Buy and follow instructions to begin your free 30-day trial
You can cancel anytime within the 30-day trial, or continue using Davis's Drug Guide to begin a 1-year subscription ($39.95)